Clinical trial
Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)
NCT00369837 · The Medicines Company, Industry · Completed
Key facts
| NCT number | NCT00369837 |
|---|---|
| Title | Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY) |
| Official title | Evaluation of the Effect of Ultrashort-Acting Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY) |
| Acronym | VELOCITY |
| Lead sponsor | The Medicines Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | clevidipine |
| Enrollment | 131 |
| Start date | Sep 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Aug 29, 2006 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: